AAAAAA

   
Results: 1-25 | 26-49
Results: 1-25/49
METHOD FOR THE DETERMINATION OF 5,5-DIPHENYLBARBITURIC ACID AND ITS SEPARATION FROM 1,3-DIMETHOXYMETHYL-5,5-DIPHENYLBARBITURIC ACID IN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY
Authors: THACKER DL ABERNETHY DR RAINES A FLOCKHART DA
Citation: Dl. Thacker et al., METHOD FOR THE DETERMINATION OF 5,5-DIPHENYLBARBITURIC ACID AND ITS SEPARATION FROM 1,3-DIMETHOXYMETHYL-5,5-DIPHENYLBARBITURIC ACID IN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, Journal of chromatography B. Biomedical sciences and applications, 710(1-2), 1998, pp. 149-155
COEXPRESSION OF RECOMBINANT HUMAN L-TYPE CA2+ CHANNEL AND ANGIOTENSINAT(1A) RECEPTOR IN XENOPUS OOCYTES
Authors: SOLDATOV NM OZ M MELIA MT ABERNETHY DR MORAD M
Citation: Nm. Soldatov et al., COEXPRESSION OF RECOMBINANT HUMAN L-TYPE CA2+ CHANNEL AND ANGIOTENSINAT(1A) RECEPTOR IN XENOPUS OOCYTES, The FASEB journal, 12(4), 1998, pp. 2537-2537
GLUTATHIONE IS A COFACTOR FOR H2O2-MEDIATED STIMULATION OF CA2-INDUCED CA2+ RELEASE IN CARDIAC MYOCYTES()
Authors: SUZUKI YJ CLEEMANN L ABERNETHY DR MORAD M
Citation: Yj. Suzuki et al., GLUTATHIONE IS A COFACTOR FOR H2O2-MEDIATED STIMULATION OF CA2-INDUCED CA2+ RELEASE IN CARDIAC MYOCYTES(), Free radical biology & medicine, 24(2), 1998, pp. 318-325
NITRIC-OXIDE INHIBITS OCT-1 DNA-BINDING ACTIVITY IN CULTURED VASCULARSMOOTH-MUSCLE CELLS
Authors: LIU XK ABERNETHY DR ANDRAWIS NS
Citation: Xk. Liu et al., NITRIC-OXIDE INHIBITS OCT-1 DNA-BINDING ACTIVITY IN CULTURED VASCULARSMOOTH-MUSCLE CELLS, Life sciences, 62(8), 1998, pp. 739-749
MOLECULAR DETERMINANTS OF L-TYPE CA2- SEGMENT EXCHANGE ANALYSIS OF THE CARBOXYL-TERMINAL CYTOPLASMIC MOTIF ENCODED BY EXON-40-42 OF THE HUMAN ALPHA(1C) SUBUNIT GENE( CHANNEL INACTIVATION )
Authors: SOLDATOV NM OZ M OBRIEN KA ABERNETHY DR MORAD M
Citation: Nm. Soldatov et al., MOLECULAR DETERMINANTS OF L-TYPE CA2- SEGMENT EXCHANGE ANALYSIS OF THE CARBOXYL-TERMINAL CYTOPLASMIC MOTIF ENCODED BY EXON-40-42 OF THE HUMAN ALPHA(1C) SUBUNIT GENE( CHANNEL INACTIVATION ), The Journal of biological chemistry, 273(2), 1998, pp. 957-963
AGING IS ASSOCIATED WITH ALTERED VASCULAR REACTIVITY TO ANGIOTENSIN-II (AII) AND ACETYLCHOLINE (ACH)
Authors: JONES D ANDRAWIS NS ABERNETHY DR
Citation: D. Jones et al., AGING IS ASSOCIATED WITH ALTERED VASCULAR REACTIVITY TO ANGIOTENSIN-II (AII) AND ACETYLCHOLINE (ACH), Clinical pharmacology and therapeutics, 63(2), 1998, pp. 8-8
FOREARM VASCULAR-RESISTANCE (FVR) IN BLACK-AND-WHITE VOLUNTEERS GIVENACETYLCHOLINE (ACH) AND ANGIOTENSIN-II (A-II) BRACHIAL INFUSIONS
Authors: JONES D ANDRAWIS N ABERNETHY DR
Citation: D. Jones et al., FOREARM VASCULAR-RESISTANCE (FVR) IN BLACK-AND-WHITE VOLUNTEERS GIVENACETYLCHOLINE (ACH) AND ANGIOTENSIN-II (A-II) BRACHIAL INFUSIONS, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 9-9
TICLOPIDINE INHIBITION OF STEADY-STATE PHENYTOIN METABOLISM IN HUMANS
Authors: DONAHUE SR ABERNETHY DR
Citation: Sr. Donahue et Dr. Abernethy, TICLOPIDINE INHIBITION OF STEADY-STATE PHENYTOIN METABOLISM IN HUMANS, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 44-44
A NOVEL FIRST-PASS PHARMACOKINETIC MODEL FOR VERAPAMIL ENANTIOMERS AND METABOLITES - DIFFERENCES BETWEEN YOUNG AND ELDERLY PATIENTS
Authors: DUCHARME MP ANACLETO AI ABERNETHY DR WAINER IW
Citation: Mp. Ducharme et al., A NOVEL FIRST-PASS PHARMACOKINETIC MODEL FOR VERAPAMIL ENANTIOMERS AND METABOLITES - DIFFERENCES BETWEEN YOUNG AND ELDERLY PATIENTS, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 117-117
MOLECULAR DETERMINANTS OF L-TYPE CA2-42 OF THE HUMAN ALPHA(1C) SUBUNIT GENE( CHANNEL INACTIVATION IDENTIFIED BY SEGMENT EXCHANGE ANALYSIS OF THE CYTOPLASMIC MOTIF ENCODED BY EXONS 40)
Authors: SOLDATOV NM OZ M OBRIEN KA ABERNETHY DR MORAD M
Citation: Nm. Soldatov et al., MOLECULAR DETERMINANTS OF L-TYPE CA2-42 OF THE HUMAN ALPHA(1C) SUBUNIT GENE( CHANNEL INACTIVATION IDENTIFIED BY SEGMENT EXCHANGE ANALYSIS OF THE CYTOPLASMIC MOTIF ENCODED BY EXONS 40), Biophysical journal, 74(2), 1998, pp. 101-101
INHIBITION OF RECOMBINANT HUMAN L-TYPE CA2+ CHANNEL BY THE ACTIVATIONOF ANGIOTENSIN AT(1A) RECEPTORS COEXPRESSED IN XENOPUS OOCYTES
Authors: OZ M SOLDATOV NM MELIA MT SANDBERG K ABERNETHY DR MORAD M
Citation: M. Oz et al., INHIBITION OF RECOMBINANT HUMAN L-TYPE CA2+ CHANNEL BY THE ACTIVATIONOF ANGIOTENSIN AT(1A) RECEPTORS COEXPRESSED IN XENOPUS OOCYTES, Biophysical journal, 74(2), 1998, pp. 378-378
DOSE-RESPONSE CHARACTERISTICS OF MIBEFRADIL, A NOVEL CALCIUM-ANTAGONIST, IN THE TREATMENT OF ESSENTIAL-HYPERTENSION
Authors: OPARIL S KOBRIN I ABERNETHY DR LEVINE BS REIF MC SHEPHERD AM
Citation: S. Oparil et al., DOSE-RESPONSE CHARACTERISTICS OF MIBEFRADIL, A NOVEL CALCIUM-ANTAGONIST, IN THE TREATMENT OF ESSENTIAL-HYPERTENSION, American journal of hypertension, 10(7), 1997, pp. 735-742
PHARMACOLOGICAL PROPERTIES OF COMBINATION THERAPIES FOR HYPERTENSION
Authors: ABERNETHY DR
Citation: Dr. Abernethy, PHARMACOLOGICAL PROPERTIES OF COMBINATION THERAPIES FOR HYPERTENSION, American journal of hypertension, 10(3), 1997, pp. 13-16
DISCUSSION - RECENT DATA ON THE SAFETY AND EFFICACY OF NEWER THERAPIES IN THE MANAGEMENT OF HYPERTENSION
Authors: NEUTEL J ABERNETHY DR MOSER M GIFFORD RW FRISHMAN WH
Citation: J. Neutel et al., DISCUSSION - RECENT DATA ON THE SAFETY AND EFFICACY OF NEWER THERAPIES IN THE MANAGEMENT OF HYPERTENSION, American journal of hypertension, 10(3), 1997, pp. 24-26
ELEVATED BLOOD-PRESSURE IN SPONTANEOUSLY HYPERTENSIVE RATS CONSUMING A HIGH SUCROSE DIET IS ASSOCIATED WITH ELEVATED ANGIOTENSIN-II AND IS REVERSED BY VANADIUM
Authors: SHI SJ PREUSS HG ABERNETHY DR LI X JARRELL ST ANDRAWIS NS
Citation: Sj. Shi et al., ELEVATED BLOOD-PRESSURE IN SPONTANEOUSLY HYPERTENSIVE RATS CONSUMING A HIGH SUCROSE DIET IS ASSOCIATED WITH ELEVATED ANGIOTENSIN-II AND IS REVERSED BY VANADIUM, Journal of hypertension, 15(8), 1997, pp. 857-862
NEW STRATEGIES IN CARDIOVASCULAR-DISEASE MANAGEMENT - SUMMARY OF ROUND-TABLE DISCUSSION
Authors: BUHLER FR COHN JN HERMSMEYER K MENARD J ABERNETHY DR KOBRIN I PRATT CM
Citation: Fr. Buhler et al., NEW STRATEGIES IN CARDIOVASCULAR-DISEASE MANAGEMENT - SUMMARY OF ROUND-TABLE DISCUSSION, Journal of hypertension, 15, 1997, pp. 1-3
OPTIMIZED PHARMACOKINETIC AND PHARMACODYNAMIC PROFILES IN CARDIOVASCULAR-DISEASE THERAPY
Authors: ABERNETHY DR
Citation: Dr. Abernethy, OPTIMIZED PHARMACOKINETIC AND PHARMACODYNAMIC PROFILES IN CARDIOVASCULAR-DISEASE THERAPY, Journal of hypertension, 15, 1997, pp. 31-33
INFLUENCE OF ORAL-CONTRACEPTIVE USE AND CIGARETTE-SMOKING, ALONE AND TOGETHER, ON ANTIPYRINE PHARMACOKINETICS
Authors: SCAVONE JM GREENBLATT DJ ABERNETHY DR LUNA BG HARMATZ JS SHADER RI
Citation: Jm. Scavone et al., INFLUENCE OF ORAL-CONTRACEPTIVE USE AND CIGARETTE-SMOKING, ALONE AND TOGETHER, ON ANTIPYRINE PHARMACOKINETICS, Journal of clinical pharmacology, 37(5), 1997, pp. 437-441
GRAPEFRUITS AND DRUGS - WHEN IS STATISTICALLY SIGNIFICANT CLINICALLY SIGNIFICANT
Authors: ABERNETHY DR
Citation: Dr. Abernethy, GRAPEFRUITS AND DRUGS - WHEN IS STATISTICALLY SIGNIFICANT CLINICALLY SIGNIFICANT, The Journal of clinical investigation, 99(10), 1997, pp. 2297-2298
TICLOPIDINE INHIBITION OF PHENYTOIN METABOLISM MEDIATED BY POTENT INHIBITION OF CYP2C19
Authors: DONAHUE SR FLOCKHART DA ABERNETHY DR KO JW
Citation: Sr. Donahue et al., TICLOPIDINE INHIBITION OF PHENYTOIN METABOLISM MEDIATED BY POTENT INHIBITION OF CYP2C19, Clinical pharmacology and therapeutics, 62(5), 1997, pp. 572-577
ASSESSMENT OF CLINICAL-PHARMACOLOGY INFORMATION (CPI) IN DRUG LABELING
Authors: SPYKER DA HARVEY ED HARVEY BE HARVEY AM RUMACK BH PECK CC ATKINSON AJ WOOSLEY RL ABERNETHY DR CANTILENA LR
Citation: Da. Spyker et al., ASSESSMENT OF CLINICAL-PHARMACOLOGY INFORMATION (CPI) IN DRUG LABELING, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 4-4
ELEVATED BLOOD-PRESSURE IN SPONTANEOUSLY HYPERTENSIVE RATS CONSUMING A HIGH SUCROSE DIET IS ASSOCIATED WITH ELEVATED ANGIOTENSIN-II AND IS REVERSED BY VANADIUM
Authors: SHI SJ PREUSS HG ABERNETHY DR LI X JARRELL ST ANDRAWIS NS
Citation: Sj. Shi et al., ELEVATED BLOOD-PRESSURE IN SPONTANEOUSLY HYPERTENSIVE RATS CONSUMING A HIGH SUCROSE DIET IS ASSOCIATED WITH ELEVATED ANGIOTENSIN-II AND IS REVERSED BY VANADIUM, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 51-51
THALIDOMIDE PHARMACOKINETICS DO NOT CHANGE WITH CHRONIC ADMINISTRATION
Authors: DONAHUE SR COLLINS JM FLOCKHART DA ABERNETHY DR TRAPNELL CB
Citation: Sr. Donahue et al., THALIDOMIDE PHARMACOKINETICS DO NOT CHANGE WITH CHRONIC ADMINISTRATION, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 89-89
PHARMACOLOGICAL AND PHARMACOKINETIC PROFILE OF MIBEFRADIL, A T-TYPE AND L-TYPE CALCIUM-CHANNEL ANTAGONIST
Authors: ABERNETHY DR
Citation: Dr. Abernethy, PHARMACOLOGICAL AND PHARMACOKINETIC PROFILE OF MIBEFRADIL, A T-TYPE AND L-TYPE CALCIUM-CHANNEL ANTAGONIST, The American journal of cardiology, 80(4B), 1997, pp. 4-11
ENZYMATICALLY OXIDIZED LDL INCREASES DNA-SYNTHESIS AND INDUCES AP-1 DNA-BINDING ACTIVITY
Authors: DONAHUE SR ANDRAWIS NS ABERNETHY DR
Citation: Sr. Donahue et al., ENZYMATICALLY OXIDIZED LDL INCREASES DNA-SYNTHESIS AND INDUCES AP-1 DNA-BINDING ACTIVITY, The FASEB journal, 10(3), 1996, pp. 1561-1561
Risultati: 1-25 | 26-49